| Description: |
circHIPK3 is drug-responsive in breast cancer cell lines, often becoming upregulated after treatment. It is linked in the paper to EMT promotion, apoptosis suppression, and drug resistance, and is discussed as connected to PI3K/AKT-related context in MCF-7 cells. |